Little Rock, Arkansas — According to state and local economic development sources SCA Pharma plans to invest $10,000,000.00 to build out 62,000 square feet of new space in Little Rock. The company plans to occupy the new space at 8821 Knoedl Court in Little Rock, on or about August 1, 2021. According to the company website SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. SCA’s product catalog includes PCAs, Epidurals, OR/Anesthesia Syringes, and IV Admixtures for use by hospitals and health systems nationwide. Headquartered in Little Rock, AR, with a 90,000-square foot production facility in Windsor, CT, SCA’s state of the art facilities exceed USP <797> standards, and meet cGMP requirements.

To learn more about SCA Pharma, visit http://scapharma.com/

Company Contact:
Milton Boyer, Chief Executive Officer
mboyer@scapharma.com
https://www.linkedin.com/in/milton-boyer-4452213/
877-550-5059

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved